The association between arterial-end-tidal carbon dioxide difference and outcomes after out-of-hospital cardiac

Aleksandra A Abrahamowicz1, Catherine R Counts2, Kyle R Danielson3

  • 1University of Washington, Department of Internal Medicine, Seattle, WA, United States.

Resuscitation
|October 2, 2022
PubMed

Insights

The difference between partial arterial carbon dioxide (PaCO2) and end-tidal carbon dioxide (ETCO2) does not predict survival or neurological outcomes in out-of-hospital cardiac arrest (OHCA) patients. These measures may guide ventilation but are not reliable for prognostication after OHCA.

Area of Science:

  • Critical Care Medicine
  • Emergency Medicine
  • Cardiology

Background:

  • Out-of-hospital cardiac arrest (OHCA) poses significant challenges for patient survival and neurological recovery.
  • Monitoring carbon dioxide levels, specifically the difference between partial arterial carbon dioxide (PaCO2) and end-tidal carbon dioxide (ETCO2), is a potential tool in managing these patients.

Purpose of the Study:

  • To investigate the association between the PaCO2-ETCO2 difference and hospital mortality in OHCA survivors.
  • To evaluate the relationship between the PaCO2-ETCO2 difference and neurological outcomes at hospital discharge following OHCA.

Main Methods:

  • Retrospective cohort study including adult OHCA patients who achieved return of spontaneous circulation (ROSC).
  • Primary exposure: PaCO2-ETCO2 difference on hospital arrival.
  • Primary outcome: Survival to hospital discharge; Secondary outcome: Favorable neurological status. Analysis included ROC curves and multivariate logistic regression.

Main Results:

  • A total of 381 OHCA patients with qualifying CO2 values were analyzed; 160 (42%) survived.
  • The mean PaCO2-ETCO2 difference was 6.8 mmHg in survivors versus 9.0 mmHg in non-survivors (p < 0.05).
  • Adjusted analysis revealed no significant association between higher PaCO2-ETCO2 difference and hospital mortality (OR 0.99) or neurological outcome. ROC analysis showed limited predictive value for both PaCO2-ETCO2 and ETCO2.

Conclusions:

  • The PaCO2-ETCO2 difference and ETCO2 alone are not strong predictors of survival or neurological status post-OHCA.
  • While potentially useful for guiding ventilation and resuscitation efforts, these CO2 metrics should not be relied upon for prognostication in OHCA patients.
Abstract

Related Concept Videos

Assessment of Diffusion and Perfusion01:17

Assessment of Diffusion and Perfusion

Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
1.1K
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and...
471
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
194
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
276
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
287
Chemical Factors Affecting Respiration Centers01:31

Chemical Factors Affecting Respiration Centers

Chemical factors such as changing CO2, O2, and H+ levels in arterial blood play a critical role in influencing respiration depth and rates. These variations are detected by chemoreceptors—specialized sensors located in two primary body areas. Central chemoreceptors are found throughout the brain stem, including the ventrolateral medulla, while peripheral chemoreceptors are located in the aortic arch and carotid arteries.
CO2 has a potent influence on respiration and is strictly regulated....
1.2K